Protara Therapeutics Inc. Watch

from 10-Q 2 pages January 24, 2024 Re: Retention Award Opportunity

from 10-Q 2 pages Non-Employee Director Compensation Policy

from 8-K 26 pages Registration Rights Agreement

from 8-K 12 pages Common Stock Purchase Warrant Protara Therapeutics, Inc

from 8-K 15 pages Pre-Funded Common Stock Purchase Warrant Protara Therapeutics, Inc

from 8-K 53 pages Subscription Agreement

from 8-K 8 pages Separation and Consulting Agreement and Release

from 10-Q 10 pages Protara Therapeutics, Inc. Amended and Restated Executive Employment Agreement

from 10-K 9 pages Protara Therapeutics, Inc. Executive Employment Agreement

from 8-K 9 pages Separation Agreement and Release

from 10-Q 9 pages Executive Employment Agreement

from 10-Q 2 pages Each Member of the Board of Directors (The “Board”) Who Is Not Also Serving as an Employee of or Consultant to Protara Therapeutics, Inc. (The “Company”) or Any of Its Subsidiaries (Each Such Member, an “Eligible Director”) Will Receive the Compensation Described in This Amended and Restated Non-Employee Director Compensation Policy for His or Her Board Service. an Eligible Director May Decline All or Any Portion of His or Her Compensation by Giving Notice to the Company Prior to the Date Cash May Be Paid or Equity Awards Are to Be Granted, as the Case May Be. This Policy Is Effective as of March 9, 2021 (The “Effective Date”) and May Be Amended at Any Time in the Sole Discretion of the Board or the Compensation Committee of the Board. This Policy Supersedes Any Prior Agreement That Provides for Compensation Terms as of the Effective Date. Cash Compensation 1. Annual Board Service Retainer: A. All Eligible Directors: $40,000

from 8-K 9 pages Separation Agreement and Release

from 8-K 7 pages Consulting Agreement

from 10-Q 8 pages Executive Employment Agreement

from 10-Q 2 pages Protara Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy

from 10-K 121 pages 345 Pas Holding LLC, Landlord, to Protara Therapeutics Inc., Tenant Lease Premises At: 345 Park Avenue South New York, New York

from 10-Q 5 pages Amendment to the Agreement Dated June 17th, 2019

from 10-Q 9 pages Separation Agreement and Release

from 10-Q 2 pages Protara Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy